[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-464475-105":59,"doc-detail-464475-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","stool-and-blood-associated-colorectal-cancer-biomarkers-a-systematic-review","Stool-and Blood-Associated Colorectal Cancer Biomarkers - A Systematic Review","","Colorectal cancer (CRC) causes a major share of cancer deaths worldwide, and late diagnosis reduces treatment success. This systematic review evaluates simple, non-invasive biomarkers in stool and blood to enable earlier CRC detection, addressing constraints from costly and limited screening tools in low- and middle-income settings. Searches in PubMed, ScienceDirect, Medline, Web of Knowledge, and Google Scholar extracted specimen types, detection methods, and performance measures. DNA methylation and microRNA markers show strong diagnostic promise, and multi-marker panels improve accuracy for scalable screening.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stool-and-blood-associated-colorectal-cancer-biomarkers-a-systematic-review/464475/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stool-and-blood-associated-colorectal-cancer-biomarkers-a-systematic-review/464475.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-22","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are affordable, non-invasive CRC biomarkers important?","Question",{"text":113,"@type":114},"Existing screening is often expensive, invasive, or limited in availability, which restricts adoption, especially in low- and middle-income settings. Affordable non-invasive biomarkers can support earlier detection and improve outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which stool-and-blood biomarkers showed strong diagnostic performance?",{"text":118,"@type":114},"DNA methylation markers demonstrated high diagnostic potential, including combined performance for SDC2 and SHOX2 and other methylation markers such as NDRG4, SEPT9, and BCAT1. MicroRNAs (e.g., miR-21, miR-92a, miR-223, miR-182) also showed excellent diagnostic performance with high sensitivities and specificities above 75%.",{"name":120,"@type":111,"acceptedAnswer":121},"How did multi-marker panels affect diagnostic accuracy?",{"text":122,"@type":114},"Multi-marker panels, including stool and methylation-based panels, achieved higher diagnostic accuracy than individual markers. The review reports high sensitivities and strong specificity for these combined approaches, supporting cost-effective, scalable screening.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},464475,1790892278,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Systematic Review  \nStool-and Blood-Associated Colorectal Cancer Biomarkers: A Systematic Review  \nPumelela Hallom 1,2,*, Pragalathan Naidoo 1,2, Sibusiso Senzani 1, Sayed S. Kader 3  \nand Zilungile L. Mkhize-Kwitshana 1,2,4, *  \nAcademic Editor: Alfonso Baldi  \nReceived: 18 November 2025  \nRevised: 12 December 2025  \nAccepted: 21 December 2025  \nPublished: 27 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Medical Microbiology, School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Nelson R. Mandela Medical School Campus, Durban 4001, South Africa; [naidoop5@ukzn.ac.za](naidoop5@ukzn.ac.za) (P.N.); [senzanis@ukzn.ac.za](senzanis@ukzn.ac.za) (S.S.)  \n2 Division of Research Capacity Development (RCD), South African Medical Research Council (SAMRC), Tygerberg, Cape Town 7505, South Africa  \n3 Department of Surgery, University of KwaZulu Natal, Congella, Durban 4013, South Africa; [kaders@ukzn.ac.za](kaders@ukzn.ac.za)  \n4 Biomedical Sciences Department, School of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Florida Campus, Johannesburg 1710, South Africa  \n* Correspondence: [220028420@stu.ukzn.ac.za](220028420@stu.ukzn.ac.za) (P.H.); [mkhizzl@unisa.ac.za](mkhizzl@unisa.ac.za) (Z.L.M.-K.); Tel.: +27-788424564 (Z.L.M.-K.)  \nSimple Summary  \nColorectal cancer is one of the most common and deadly cancers worldwide, but many people are diagnosed too late because current screening tests are expensive, invasive, or not easily available. Early detection greatly increases the chances of successful treatment. This research aims to find simple, accurate, and non-invasive ways to detect colorectal cancer using biological markers found in blood and stool. These markers can reveal early changes in the body that happen before cancer develops. By reviewing the most promising blood and stool markers, this study highlights potential tools that could make screening easier and more accessible for everyone. The findings may guide future research toward developing affordable tests that can detect colorectal cancer earlier, reduce deaths, and improve global health outcomes.  \nAbstract  \nBackground/Objectives: Colorectal cancer (CRC) is a major contributor to cancer-related deaths worldwide. While existing screening tools are effective, their high cost and limited availability restrict widespread adoption, particularly in low-and middle-income settings. The identification of affordable, non-invasive biomarkers is therefore critical to improve early CRC detection and survival outcomes. Methods: A systematic literature search was performed through PubMed, ScienceDirect, Medline, ISI Web of Knowledge, and Google Scholar to identify studies reporting stool-and blood-based biomarkers for CRC detection. Data were extracted using a standardized template, including study details, specimen type, detection method, and diagnostic performance parameters such as sensitivity and specificity. Results: DNA methylation biomarkers demonstrated high diagnostic potential. Syndecan 2 (SDC2) and Short Stature Homeobox 2 (SHOX2) achieved a combined stool sensitivity of 91.35% . Other methylation markers, including NDRG4, SEPT9, and BCAT1, showed a composite sensitivity of 82.7% . Plasma-based methylation markers such as GATA5, FOXE1, and SYNE1 reported sensitivities ranging from 18–47% and specificities of 93–99% . Hypermethylation of SFRP2 and WIF-1 achieved 81.3% sensitivity in CRC and precursor lesions. Matrix metalloproteinases (MMP-2 and MMP-9) were elevated in CRC patients, with stool MMP-9 yielding 72.2% sensitivity and 95% specificity. A stool  \ngene panel ( UBE2N, IMPDH1, DYNC1LI1, HRASLS2) reached 96.6% sensitivity and 89.7% specificity, while a methylation-based panel (ALX4, BMP3, NPTX2, RARB, S","cbCaimgEyYRwNNy7","https://ap.wps.com/l/cbCaimgEyYRwNNy7","pdf",714454,17,"English","# Introduction\n## Current CRC detection methods\n# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions","[{\"question\":\"Why are affordable, non-invasive CRC biomarkers important?\",\"answer\":\"Existing screening is often expensive, invasive, or limited in availability, which restricts adoption, especially in low- and middle-income settings. Affordable non-invasive biomarkers can support earlier detection and improve outcomes.\"},{\"question\":\"Which stool-and-blood biomarkers showed strong diagnostic performance?\",\"answer\":\"DNA methylation markers demonstrated high diagnostic potential, including combined performance for SDC2 and SHOX2 and other methylation markers such as NDRG4, SEPT9, and BCAT1. MicroRNAs (e.g., miR-21, miR-92a, miR-223, miR-182) also showed excellent diagnostic performance with high sensitivities and specificities above 75%.\"},{\"question\":\"How did multi-marker panels affect diagnostic accuracy?\",\"answer\":\"Multi-marker panels, including stool and methylation-based panels, achieved higher diagnostic accuracy than individual markers. The review reports high sensitivities and strong specificity for these combined approaches, supporting cost-effective, scalable screening.\"}]","Stool-and Blood-Associated Colorectal Cancer Biomarkers - A Systematic Review | PDF",1790768241,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/f453ebb74868e5ef4a46394b038b2b0d.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/a4c1ad999f37bf236bc19d3d8dae9478.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/45db5d5e6a20b085c4f7d1685762243c.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1c1c9741a320f755a40b4cc58728fe59.webp",980,1385]